Announcements - OBI Pharma 台灣浩鼎

2021.Nov.26

Announcement of the resolution of the Board of Directors of the Company to issue common shares through cash capital increase

2021.Nov.12

Supplementary statements on news article

2021.Nov.11

Intellectual property rights licensing of OBI’s cancer therapies in China has been granted by MOEAIC

2021.Nov.05

Announcement of amendment of the regulations for issuance and subscription of 2021 employee stock options

2021.Nov.05

Announcement of the Consolidated Financial Statements for the third quarter of 2021 were authorized for issuance by the Board of Directors

2021.Nov.03

OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Re-election of directors and supervisors at the 2021 annual shareholders’ meeting

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. that the Company’s Board of Directors resolved to appoint Ms. Tessie Che as Chairperson

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Resolution to lift the non-competition restrictions for new directors

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of important resolutions of the 2021 annual shareholders’ meeting

News

Latest News

Events

Latest events